The New Paper

December 30, 2020

UK grants emergency approval for AstraZeneca coronavirus vaccine

The UK granted emergency approval for AstraZeneca’s coronavirus vaccine yesterday. The vaccine, which was found to be ~70% effective in late-stage clinical trials, is the second to receive approval in the UK and third to receive approval in a Western nation (joining the Pfizer-BioNTech and Moderna vaccines). 

Extra: The AstraZeneca vaccine can be stored at normal refrigeration temperatures, making it less logistically challenging to store and distribute than the Pfizer and Moderna vaccines (which have to be stored at -94 degrees Fahrenheit).
This story is from the December 30, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.